Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126618202 | 12661820 | 2 | F | 20160822 | 20160817 | 20160826 | EXP | NL-UCBSA-2016031194 | UCB | RUIJTER BJ, VAN PUTTEN MJ, HOFMEIJER J. GENERALIZED EPILEPTIFORM DISCHARGES IN POSTANOXIC ENCEPHALOPATHY: QUANTITATIVE CHARACTERIZATION IN RELATION TO OUTCOME. EPILEPSIA. 2015;56(11):1845-54 | 0.00 | Y | 0.00000 | 20160826 | MD | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126618202 | 12661820 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | UNKNOWN DOSE | U | U | 21035 | |||||||||
| 126618202 | 12661820 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | U | U | 21035 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126618202 | 12661820 | 1 | Status epilepticus |
| 126618202 | 12661820 | 2 | Off label use |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126618202 | 12661820 | DS |
| 126618202 | 12661820 | DE |
| 126618202 | 12661820 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126618202 | 12661820 | Coma | |
| 126618202 | 12661820 | Death | |
| 126618202 | 12661820 | Disability | |
| 126618202 | 12661820 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |